A Vaccine Task Force (VTF) is being set up by Prime Minister’s Office (PMO) for focussed research on corona vaccines has allowed research institutions and laboratories to use patient samples for research and development (R&D) purposes. The government has also framed detailed guidelines for the sharing of bio-specimen and data for such research among institutions and circulated them in April. Many firms like Zydus Cadila, Serum Institute of India, Panacea Biotech, and Bharat Biotech are working to develop the vaccine.India’s drug regulator, the Central Drugs Standard Control Organisation, has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘Covaxin’, making it the first indigenous Covid-19 vaccine candidate to receive this approval. These trials are scheduled to start across India in July. It is developed in collaboration with ICMR and NIV.It will begin its Phase-I and Phase II trials, which brings India close to domestically produced Covid-19 vaccine for its population. It is a positive sign as the number of cases is surging, especially in the national capital. The first phase is conducted on a small group of individuals, trying to find what dosage of the vaccine is safe for use, whether it is effective in building their immunity to the virus and whether there are any side effects. The second phase is conducted on a larger group comprising hundreds of persons fitting the description of those for whom the vaccine is intended using characteristics like age and sex. This phase tests how effective the vaccine is on the population group being studied.The whole process of vaccine approval comprises of 3 Phases with final approval for general usage for the whole population, after studying all the effects, and long-term consequences. India is still in the race by reaching an advanced stage in this process. India is in collaboration with the USA for developing a vaccine. India is amongst the largest manufacturer of generic drugs and vaccines in the world. It is home to major vaccine makers making doses against polio, meningitis, pneumonia, rotavirus, BCG, measles, mumps, and rubella, among other diseases. With such efforts, it is highly likely that India may succeed, with many countries like Israel to make claims of the final vaccine which can be used. It takes years if not decades to make a vaccine. But by mid-2021 we can expect a vaccine, which is a high need in the world as the number of cases and deaths are soaring up.